Clinical trial
Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM
Active, not recruiting · Phase 4 · 1 countries · Registry ID NCT06860841
What this study is about
This study evaluates the efficacy of D-Chiro-Inositol (DCI) as an add-on therapy to metformin in improving insulin resistance, measured by the HOMA index, in people with overweight or obesity and type 2 diabetes mellitus (T2DM). Secondary outcomes include glycemic variability, indirect calorimetry, respiratory quotient, and other metabolic parameters.
Basic eligibility
Full registry criteria
Treatments and study arms
D-Chiro-Inositol Combined with Metformin
D-chiro-Inositol will be administered for 14 days,1 cp after lunch and 1 cp after dinner in addition to preexisting metformin therapy
Placebo in combination with metformin
placebo will be administerd for 14 days, 1 cp after lunch and 1 cp after dinner in addition to pre-existing metformin therapy
Primary outcomes
fasting glucose and insulin will be measured
Study locations
1 locations were listed when this page was built. The first 40 are shown.